Compare Manhattan Associates Inc (MANH) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs 22nd Century Group Inc — how do they compare? Manhattan Associates Inc trades at $204.89 (market cap $12.06B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Manhattan Associates Inc is far larger — about 19399.4× 22nd Century Group Inc's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and 22nd Century Group Inc for 32 Days on average.
| MANH | XXII | |
|---|---|---|
Market Cap | $12.06B | $621.67K |
Volume | 376,150 | 45,625 |
Sector | Technology | Consumer Staples |
52-Week High | $223.76 | $483.00 |
52-Week Low | $120.88 | $0.80 |
Typical Hold Time | 12 Days | 32 Days |
Enterprise Value | $11.93B | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MANH trades at $204.89, up 1.38% on the day, with a bullish technical trend and strong profitability metrics including a 96.38% ROE and 18.67% net income margin. The stock has consistently beaten earnings estimates in recent quarters, though high valuation ratios like a P/E of 59.26 suggest premium pricing. Recent news includes a mix of positive product launches and ongoing legal investigations into fiduciary duties.
The outlook is cautiously optimistic, supported by analyst consensus and solid fundamentals, but risks include the high valuation, potential legal overhangs, and a projected decline in net income for 2026. Upside potential exists toward the $210.50 consensus target if execution remains strong.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
